130081 20240319081001.0 doi 10.3390/jcm11051258 sideral 128158 ART-2022-128158 eng Latorre, E. Universidad de Zaragoza (orcid)0000-0002-5797-3909 Special Issue “Clinical Advances in Chronic Intestinal Diseases Treatment” 2022 Access copy available to the general public Unrestricted During the last decades, the management of patients with chronic intestinal diseases has experienced remarkable progress from both diagnostic and therapeutic point of view. Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are the best known and with the highest incidence and prevalence around the world among chronic intestinal pathologies. Both chronic conditions display a significant overlap in terms of symptoms, pathophysiology, and treatments. However, these chronic intestinal diseases are poorly characterized and the understanding about is limited. New clinical approaches with novel mechanisms of action may offer more efficient options for treatment of chronic intestinal diseases, especially in those patients who are not optimally characterized or controlled. info:eu-repo/semantics/openAccess by http://creativecommons.org/licenses/by/3.0/es/ 3.9 2022 MEDICINE, GENERAL & INTERNAL 58 / 169 = 0.343 2022 Q2 T2 0.935 2022 Medicine (miscellaneous) 2022 Q1 5.4 2022 info:eu-repo/semantics/other info:eu-repo/semantics/publishedVersion Mesonero, J. E. Universidad de Zaragoza (orcid)0000-0003-4758-3998 1012 410 Universidad de Zaragoza Dpto. Farmac.Fisiol.y Med.L.F. Área Fisiología 1002 050 Universidad de Zaragoza Dpto. Bioq.Biolog.Mol. Celular Área Biología Celular 11, 5 (2022), 1258 [3 pp] J. clin.med. Journal of Clinical Medicine 2077-0383 186687 http://zaguan.unizar.es/record/130081/files/texto_completo.pdf Versión publicada 2863680 http://zaguan.unizar.es/record/130081/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:130081 articulos driver 2024-03-18-14:08:07 ARTICLE